BioCentury
ARTICLE | Clinical News

INP 341 regulatory update

August 4, 2008 7:00 AM UTC

EMEA’s Committee for Orphan Medical Products (COMP) issued a positive opinion to grant Orphan Drug designation for Innate’s INP 341 to treat severe burns. INP 341, which is in preclinical development,...